PD Dr. Markus Hecht

Medizinische Fakultät Department of Radiation Oncology

Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) Rudolf J, Büttner-Herold M, Erlenbach-Wuensch K, Posselt R, Jeßberger J, Haderlein M, Hecht M, et al. Journal article Erste erfolgversprechende Ergebnisse der Kombination aus Strahlentherapie und Pembrolizumab beim metastasierten nichtkleinzelligen Lungenkarzinom (2020) Hecht M, Gaipl U, Fietkau R Journal article Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020) Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al. Journal article Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results (2019) Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Müller SK, et al. Journal article Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, et al. Conference contribution Stereotaktisch ablative Bestrahlung als Standardtechnik beim NSCLC im Stadium I bestätigt (2019) Hecht M, Fietkau R Journal article CD8+and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer (2019) Echarti A, Hecht M, Büttner-Herold M, Haderlein M, Hartmann A, Fietkau R, Distel L Journal article Influence of the Kinase Inhibitor Palbociclib on the Migration of malignant and non-malignant Cells under Irradiation (2019) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Prognostic Importance of the CD8-based Immune Status Inflamed, immune-Excluded, and immune Desert in Head and Neck Cancer Patients can be further subdivided by regulatory T Cells (2019) Echarti A, Hecht M, Fietkau R, Distel L Conference contribution Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood (2019) Hecht M, Donaubauer AJ, Becker I, Rutzner S, Lubgan D, Lettmaier S, Haderlein M, et al. Conference contribution